Wisconsin bills · 2025-2026 Regular Session
Wisconsin SB 492
Relating to: coverage of nonopioid drug alternatives for the treatment and management of pain.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Keyeski (Democratic)
- Dassler-Alfheim (Democratic)
- James (Republican)
Summary
No official summary is available for this bill.
Latest action(Mar 23, 2026): Failed to pass pursuant to Senate Joint Resolution 1
Text versions
Roll-call votes
State vote data last updated Oct 15, 2026, 8:04 PM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Jan 22, 2026 Senate | Report passage by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 2, Noes 3 | fail | Set your home in Wisconsin to see |
Actions
- Mar 23, 2026 · Senate
Failed to pass pursuant to Senate Joint Resolution 1 - Jan 22, 2026 · Senate
Available for scheduling - Jan 22, 2026 · Senate
Report passage by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 2, Noes 3 - Jan 22, 2026 · Senate
Executive action taken - Jan 22, 2026 · Senate
Senator Keyeski withdrawn as a coauthor - Dec 16, 2025 · Senate
Senate Amendment 1 offered by Senator James - Oct 8, 2025 · Senate
Public hearing held - Oct 7, 2025 · Senate
Commissioner of Insurance report received pursuant to s.601.423(2), Wisconsin Statutes - Oct 2, 2025 · Senate
Read first time and referred to Committee on Mental Health, Substance Abuse Prevention, Children and Families - Oct 2, 2025 · Senate
Introduced by Senators James, Dassler-Alfheim and Keyeski; cosponsored by Representatives Moses, Armstrong, Behnke, Duchow, Gundrum, Knodl, Melotik, Mursau, O'Connor, Wichgers and Murphy